Fan Noise Control by Enclosure Modification

In the present study, a structural modification approach to reducing the sound power radiated by an axial fan mounted to an enclosure is described. An axial fan operating in free-space exhibits a dipole-like radiation pattern at sufficiently low frequencies that the source is compact. When a fan is mounted to an enclosure, however, the sound radiation pattern becomes monopole-like since only one side of the fan is exposed to the exterior space; thus it radiates more efficiently than the same fan operating in free-space. Also, it is possible for the source level to be amplified by coupling with the interior resonances of the enclosure. The radiation enhancement can be suppressed by introducing a second “path” that allows the sound fields on both sides of the fan to interact with each other while also providing damping for the acoustical cavity, thus reducing the radiation efficiency of a fan towards its free-space value. Experimental results are presented here to demonstrate this effect. The sound fields radiated by two fans mounted to a consumer electronics enclosure were visualized by using near-field acoustical holography, and the baseline results were compared with those for various enclosure modifications. First, the top of the enclosure was replaced by an acoustically-transparent mylar sheet. Then two types of acoustical openings, i.e., a grilled port and a perforated panel, were introduced on the top of the original enclosure close to fan locations. A significant reduction of sound power resulted from the enclosure modifications, in particular at the fundamental and twice the blade passing frequencies, and a clearer conversion from a monopole to a dipole-like radiation pattern was observed when the size of the opening was made larger

Excitation of helically-trapped-energetic-ion driven resistive interchange modes with intense deuterium beam injection and enhanced effect on beam ions/bulk plasmas of LHD

Energetic ion driven resistive InterChange modes (EICs) accompanying repeated bursts of the magnetic fluctuations were found in hydrogen campaign of large helical device. The pressure gradient of helically trapped energetic particles, which are mainly produced by perpendicularly injected beams, drives this mode. Recently, perpendicular neutral beam injection (PERP-NBI) systems are upgraded for deuterium plasma campaign. The beam energies of the two PERP-NBIs are increased from 40/40 keV to 60/80 keV, respectively. And the injection powers increase from 6/6 MW to 9/9 MW, as well. As results of these upgrades of NBIs, the β value of helically trapped energetic ions, , has increased up to  ∼0.35% and induced EICs with larger bursts and smaller repetition frequencies. It is found that the threshold of to excite EICs increases with deuterium PERP-NBIs. The amplitude of each burst and effect on energetic beam ions become larger when is larger. In addition, a large electrostatic potential about  −25 kV is observed when EICs are excited, which is about two times larger than the potential observed in hydrogen campaign. The transient increases of the electron density and temperature in edge regions are clearly observed when the electrostatic potential is formed

Present Status in the Development of 6 MeV Heavy Ion Beam Probe on LHD

In order to measure the potential in Large Helical Device (LHD), we have been developing a heavy ion beam probe (HIBP). For probing beam, gold beam is used, which is accelerated by a tandem accelerator up to the energy of 6 MeV. The experiments for calibration of beam orbit were done, and experimental results were compared with orbit calculations. The experimental results coincided fairly with the calculation results. After the calibration of the beam orbit, the potential in plasma was tried to measure with the HIBP. The experimental data showed positive potential in a neutral beam heating phase on the condition of ne ? 5 × 10^18 m^-3, and the increase of potential was observed when the additional electron cyclotron heating was applied to this plasma. The time constant for this increase was about a few tens ms, which was larger than a theoretical expectation. In the spatial position of sample volume, we might have an ambiguity in this experiment

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.

OBJECTIVE:This trial compared the efficacy and safety of transarterial chemoembolisation (TACE) plus sorafenib with TACE alone using a newly established TACE-specific endpoint and pre-treatment of sorafenib before initial TACE. DESIGN:Patients with unresectable hepatocellular carcinoma (HCC) were randomised to TACE plus sorafenib (n=80) or TACE alone (n=76). Patients in the combination group received sorafenib 400 mg once daily for 2-3 weeks before TACE, followed by 800 mg once daily during on-demand conventional TACE sessions until time to untreatable (unTACEable) progression (TTUP), defined as untreatable tumour progression, transient deterioration to Child-Pugh C or appearance of vascular invasion/extrahepatic spread. Co-primary endpoints were progression-free survival (PFS), which is not a conventional one but defined as TTUP, or time to any cause of death plus overall survival (OS). Multiplicity was adjusted by gatekeeping hierarchical testing. RESULTS:Median PFS was significantly longer in the TACE plus sorafenib than in the TACE alone group (25.2 vs 13.5 months; p=0.006). OS was not analysed because only 73.6% of OS events were reached. Median TTUP (26.7 vs 20.6 months; p=0.02) was also significantly longer in the TACE plus sorafenib group. OS at 1 year and 2 years in TACE plus sorafenib group and TACE alone group were 96.2% and 82.7% and 77.2% and 64.6%, respectively. There were no unexpected toxicities. CONCLUSION:TACE plus sorafenib significantly improved PFS over TACE alone in patients with unresectable HCC. Adverse events were consistent with those of previous TACE combination trials. TRIAL REGISTRATION NUMBER:NCT01217034

Hydrostaticity and hidden order: effects of experimental conditions on the temperature-pressure phase diagram of URu2Si2

The pressure-dependence of the hidden order phase transition of URu2Si2 is shown to depend sensitively upon the quality of hydrostatic pressure conditions during electrical resistivity measurements. Hysteresis in pressure is demonstrated for two choices of pressure medium: the commonly-used mixture of 1:1 Fluorinert FC70/FC77 and pure FC75. In contrast, no hysteresis is observed when the pressure medium is a 1:1 mixture of n-pentane/isoamyl alcohol, as it remains hydrostatic over the entire studied pressure range. Possible ramifications for the interpretation of the temperature-pressure phase diagram of URu2Si2 are discussed.Comment: 9 pgs, 2 figs, accepted by High Pressure Researc

Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarteria Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma

IntroductionSeveral clinical trials comparing the efficacy and safety of transarterial chemoembolization (TACE) plus molecular-targeted agents versus TACE alone revealed no clinical benefits in progression-free survival (PFS) or overall survival (OS). Here, we report the final OS analysis from the TACTICS trial, which previously demonstrated significant improvement in PFS with TACE plus sorafenib in patients with unresectable hepatocellular carcinoma (HCC) (NCT01217034).MethodsPatients with unresectable HCC were randomized to a TACE plus sorafenib group (N = 80) or a TACE alone group (N = 76). Patients in the combination treatment group received sorafenib 400 mg once daily for 2-3 weeks before TACE, followed by 800 mg once daily during on-demand conventional TACE sessions until time to untreatable progression. In this trial, TACE-specific PFS was used. TACE-specific PFS is defined as the time from randomization to progressive disease (PD) or death from any cause, and PD was defined as untreatable progression, caused by the inability of a patient to further receive or benefit from TACE for reasons that include intrahepatic tumor progression (25% increase vs. baseline) according to response evaluation criteria in cancer of the liver, the detection of extrahepatic spread, vascular invasion, or transient deterioration of liver function to Child-Pugh C after TACE.ResultsAt the cut-off date of July 31, 2020, 131 OS events were observed. The median OS was 36.2 months with TACE plus sorafenib and 30.8 months with TACE alone (hazard ratio [HR] = 0.861; 95% confidence interval [CI], 0.607-1.223; p = 0.40, ΔOS, 5.4 months). The updated PFS was 22.8 months with TACE plus sorafenib and 13.5 months with TACE alone (HR = 0.661; 95% CI, 0.466-0.938; p = 0.02). Post-trial treatments with active procedures/agents were received by 47 (58.8%) patients in the TACE plus sorafenib group and 58 (76.3%) in the TACE alone group (p = 0.01). In post hoc analysis, PFS and OS benefit were shown in HCC patients with tumor burden beyond up-to-7 criteria.ConclusionsIn TACTICS trial, TACE plus sorafenib did not show significant OS benefit over TACE alone; however, clinical meaningful OS prolongation and significantly improved PFS was observed. Thus, the TACE plus sorafenib can be considered a choice of treatment in intermediate-stage HCC, especially in patients with high tumor burden. Trial Registration: NCT01217034

Recent Results from LHD Experiment with Emphasis on Relation to Theory from Experimentalist’s View

he Large Helical Device (LHD) has been extending an operational regime of net-current free plasmas towardsthe fusion relevant condition with taking advantage of a net current-free heliotron concept and employing a superconducting coil system. Heating capability has exceeded 10 MW and the central ion and electron temperatureshave reached 7 and 10 keV, respectively. The maximum value of β and pulse length have been extended to 3.2% and 150 s, respectively. Many encouraging physical findings have been obtained. Topics from recent experiments, which should be emphasized from the aspect of theoretical approaches, are reviewed. Those are (1) Prominent features in the inward shifted configuration, i.e., mitigation of an ideal interchange mode in the configuration with magnetic hill, and confinement improvement due to suppression of both anomalous and neoclassical transport, (2) Demonstration ofbifurcation of radial electric field and associated formation of an internal transport barrier, and (3) Dynamics of magnetic islands and clarification of the role of separatrix

Realization of high Ti plasmas and confinement characteristics of ITB plasmas in the LHD deuterium experiments

The deuterium (D) operation was initiated in the LHD in 2017. In the first campaign of the D experiments, we successfully extended the high temperature regime in the LHD. The new record of the ion temperature (Ti) of 10 keV associated with the ion internal transport barrier (ITB) was achieved due to several operational optimization. The thermal confinement characteristics of ITB plasmas were compared between hydrogen and D discharges. The effective ion thermal diffusivity of the ion-ITB plasmas was found to be smaller in the D discharges than that in the H discharges. The profiles of the Ti, the electron density, and the impurity of the high Ti plasmas strongly depended on the magnetic configuration and these profiles tended to peaked in the inward-shifted configuration. It was also found that the electron thermal confinement of the electron-ITB plasmas was clearly improved in the deuterium case. The GKV simulation showed the linear growth rate of TEM/ITG reduced in the plasmas with D both for the ion ITB and the electron ITB plasmas and qualitatively agreed with the tendency of the change in the thermal diffusivity obtained from the power balance analysis